Redwood Financial Network Corp Sells 15 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Redwood Financial Network Corp reduced its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,415 shares of the biotechnology company’s stock after selling 15 shares during the period. Redwood Financial Network Corp’s holdings in Axon Enterprise were worth $841,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. New Wave Wealth Advisors LLC purchased a new position in shares of Axon Enterprise in the fourth quarter worth about $40,000. Y.D. More Investments Ltd bought a new position in Axon Enterprise in the 4th quarter worth approximately $45,000. Stonebridge Financial Group LLC purchased a new position in Axon Enterprise in the 4th quarter valued at approximately $53,000. GPS Wealth Strategies Group LLC raised its holdings in Axon Enterprise by 74.1% during the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after acquiring an additional 40 shares during the period. Finally, Berbice Capital Management LLC bought a new stake in Axon Enterprise during the 4th quarter valued at $59,000. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $728.53 on Thursday. The stock’s 50-day simple moving average is $576.22 and its two-hundred day simple moving average is $589.48. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $732.17. The firm has a market capitalization of $56.72 billion, a P/E ratio of 188.25, a P/E/G ratio of 5.17 and a beta of 1.24. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.07. The company had revenue of $603.63 million for the quarter, compared to analysts’ expectations of $585.67 million. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. Axon Enterprise’s revenue for the quarter was up 31.3% compared to the same quarter last year. During the same period in the prior year, the business earned $1.15 earnings per share. As a group, equities analysts anticipate that Axon Enterprise, Inc. will post 5.8 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently commented on AXON shares. The Goldman Sachs Group raised their price target on Axon Enterprise from $730.00 to $830.00 and gave the stock a “buy” rating in a report on Wednesday. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Craig Hallum lowered Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Finally, Needham & Company LLC increased their price target on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a report on Thursday, May 8th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $652.73.

Insiders Place Their Bets

In related news, Director Julie A. Cullivan sold 657 shares of the stock in a transaction on Monday, May 12th. The stock was sold at an average price of $700.00, for a total value of $459,900.00. Following the transaction, the director now owns 1,735 shares of the company’s stock, valued at $1,214,500. This represents a 27.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Matthew R. Mcbrady sold 400 shares of the firm’s stock in a transaction dated Wednesday, May 14th. The shares were sold at an average price of $718.40, for a total value of $287,360.00. Following the sale, the director now owns 3,492 shares in the company, valued at $2,508,652.80. The trade was a 10.28% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 23,764 shares of company stock valued at $14,856,635 in the last quarter. Corporate insiders own 4.40% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.